In Yekaterinburg, scientists at the Ural Federal University have created anti-cancer drugs that demonstrate a tenfold superiority over traditional chemotherapy. Innovative complexes with carbenes have already passed initial tests and are ready for preclinical studies.
The new drug is able to effectively fight even those malignant tumors that have developed resistance to existing treatments. Unlike standard cisplatin, used in chemotherapy, the development of Ural scientists works at significantly lower dosages.
The principle of operation of the innovative drug is based on blocking mitochondria — the power plants of cancer cells. Experiments have proven that new compounds successfully suppress the growth and division of malignant cells in the tissues of the brain, lungs, and liver.
A unique advantage of the development is the ability to act effectively even at low concentrations. This means that patients will receive more gentle treatment with minimal side effects.
Currently, scientists have completed work on the molecular structure of the drug and are preparing for the next stage — preclinical trials. After the successful completion of all stages of testing, the new drug could become a real breakthrough in the treatment of oncological diseases.
Read more materials on the topic:
Nose as a road to the brain: scientists have found a new way to deliver drugs
Rostec: the MedUza 008 tumor treatment device will undergo first tests in the second half of 2025
Russian researchers have synthesized an antibiotic against resistant Staphylococcus
Now on home
